-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Cadrenal Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2022 to 2023.
- Cadrenal Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -2.18 USD/shares, a 116% decline year-over-year.
- Cadrenal Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -1.47 USD/shares, a 33.5% increase year-over-year.
- Cadrenal Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -0.62 USD/shares, a 27.1% increase from 2022.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)